Related references
Note: Only part of the references are listed.Androgen Receptor in Breast Cancer-Clinical and Preclinical Research Insights
Aristomenis Anestis et al.
MOLECULES (2020)
The prognostic value of androgen receptor (AR) in HER2-enriched metastatic breast cancer
Xinyue Wang et al.
ENDOCRINE-RELATED CANCER (2020)
Androgen Receptor in Breast Cancer: From Bench to Bedside
Mengyao Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies
Kevin H. Kensler et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Androgen receptor: A promising therapeutic target in breast cancer
Stella K. Vasiliou et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
Shristi Bhattarai et al.
CANCERS (2019)
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L. Gerratana et al.
CANCER TREATMENT REVIEWS (2018)
Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
Angela Santonja et al.
Oncotarget (2018)
The Androgen Receptor in Breast Cancer
Pia Giovannelli et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Androgen Receptor Expression in an Indian Breast Cancer Cohort with Relation to Molecular Subtypes and Response to Neoadjuvant Chemotherapy - Prospective Clinical Study
Akshay Anand et al.
BREAST CARE (2017)
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis
Mohammad A. Aleskandarany et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
Changjun Wang et al.
ONCOTARGET (2016)
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
Ramesh Narayanan et al.
CANCERS (2016)
Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
Brian D. Lehmann et al.
PLOS ONE (2016)
A Targetable Androgen Receptor-Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers
Damoun Safarpour et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2015)
Targeting the androgen receptor in prostate and breast cancer: several new agents in development
Tracy Proverbs-Singh et al.
ENDOCRINE-RELATED CANCER (2015)
Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
Yoonseok Kim et al.
JOURNAL OF BREAST CANCER (2015)
Targeting the Androgen Receptor in Breast Cancer
KeeMing Chia et al.
CURRENT ONCOLOGY REPORTS (2015)
Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer
Jung Eun Choi et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Androgenic pathways in the progression of triple-negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes
Keely M. McNamara et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Complexities of androgen receptor signalling in breast cancer
Keely M. McNamara et al.
ENDOCRINE-RELATED CANCER (2014)
Revising the role of the androgen receptor in breast cancer
F. M. Fioretti et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Expression of the Androgen Receptor, pAkt, and pPTEN in Breast Cancer and Their Potential in Prognostication
Aisha Sultana et al.
TRANSLATIONAL ONCOLOGY (2014)
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R. Cochrane et al.
BREAST CANCER RESEARCH (2014)
Expression of androgen receptors in triple negative breast carcinomas
Ivana Mrklic et al.
ACTA HISTOCHEMICA (2013)
13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013)
Michael Untch et al.
BREAST CARE (2013)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
Rocio Garcia-Becerra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers
Isabell Witzel et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis
Qing Qu et al.
PLOS ONE (2013)
Decreased Androgen Receptor Expression Is Associated With Distant Metastases in Patients With Androgen Receptor Expressing Triple-Negative Breast Carcinoma
Lisa M. Sutton et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer
Jonas Bergh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Research Resource: Interplay between the Genomic and Transcriptional Networks of Androgen Receptor and Estrogen Receptor α in Luminal Breast Cancer Cells
Eleanor F. Need et al.
MOLECULAR ENDOCRINOLOGY (2012)
Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray
Jiehua He et al.
MEDICAL ONCOLOGY (2012)
A refined molecular taxonomy of breast cancer
M. Guedj et al.
ONCOGENE (2012)
Expression and clinical significance of androgen receptor in triple negative breast cancer
Xiang Luo et al.
Chinese Journal of Cancer (2012)
Expression of androgen receptor in breast cancer and its significance as a prognostic factor
Q. Yu et al.
ANNALS OF ONCOLOGY (2011)
Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
S. Park et al.
ANNALS OF ONCOLOGY (2011)
Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy
Sibylle Loibl et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
Min Ni et al.
CANCER CELL (2011)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Expression of androgen receptors in primary breast cancer
S. Park et al.
ANNALS OF ONCOLOGY (2010)
Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers
Isabella Castellano et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Androgen receptor is frequently expressed in HER2-positive, ER/PR-negative breast cancers
Donata Micello et al.
VIRCHOWS ARCHIV (2010)
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Amelia A. Peters et al.
CANCER RESEARCH (2009)
Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2009)
Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers
Yoshinari Ogawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2008)
The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies
Erik von Elm et al.
ANNALS OF INTERNAL MEDICINE (2007)
Progress and promise:: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2007)
Guidance for fluorescence in situ hybridization testing in hematologic disorders
Daynna J. Wolff et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Androgen receptor expression in estrogen receptor-negative breast cancer - Immunohistochemical, clinical, and prognostic associations
SN Agoff et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women:: Analysis of survival and update of efficacy from the international letrozole breast cancer group
H Mouridsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
